Furo[2,3-b]pyridine-based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation. Part 1

被引:24
作者
Debenham, John S. [1 ]
Madsen-Duggan, Christina B. [1 ]
Toupence, Richard B. [1 ]
Walsh, Thomas F. [1 ]
Wang, Junying [1 ]
Tong, Xinchun [1 ]
Kumar, Sanjeev [2 ]
Lao, Julie [3 ]
Fong, Tung M. [3 ]
Xiao, Jing Chen [3 ]
Huang, Cathy R-R. C. [3 ]
Shen, Chun-Pyn [3 ]
Feng, Yue [3 ]
Marsh, Donald J. [3 ]
Stribling, D. Sloan [4 ]
Shearman, Lauren P. [4 ]
Strack, Alison M. [4 ]
Goulet, Mark T. [1 ]
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Drug Metab, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA
[4] Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA
关键词
CB1R; Cannabinoid; Obesity; Inverse agonist; Furopyridine; BARIATRIC SURGERY; CB1; 5,6-DIARYLPYRIDINES; ANTAGONISTS; DISCOVERY; MORTALITY; OUTCOMES; OBESITY;
D O I
10.1016/j.bmcl.2009.12.065
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis, SAR and binding affinities of cannabinoid-1 receptor (CB1R) inverse agonists based on furo[2,3-b]pyridine scaffolds are described. Food intake, mechanism specific efficacy, pharmacokinetic, and metabolic evaluation of several of these compounds indicate that they are effective orally active modulators of CB1R. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1448 / 1452
页数:5
相关论文
共 18 条
[1]   Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: Results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers [J].
Addy, Carol ;
Li, Susie ;
Agrawal, Nancy ;
Stone, Julie ;
Majumdar, Anup ;
Zhong, Ling ;
Li, Hankun ;
Yuan, Jinyu ;
Maes, Andrea ;
Rothenberg, Paul ;
Cote, Josee ;
Rosko, Kim ;
Cummings, Corinne ;
Warrington, Steven ;
Boyce, Malcolm ;
Gottesdiener, Keith ;
Stoch, Aubrey ;
Wagner, John .
JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (04) :418-427
[2]   Bariatric surgery: A systematic review and meta-analysis [J].
Buchwald, H ;
Avidor, Y ;
Braunwald, E ;
Jensen, MD ;
Pories, W ;
Fahrbach, K ;
Schoelles, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (14) :1724-1737
[3]  
Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725
[4]   Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation [J].
Debenham, John S. ;
Madsen-Duggan, Christina B. ;
Wang, Junying ;
Tong, Xinchun ;
Lao, Julie ;
Fong, Tung M. ;
Schaeffer, Marie-Therese ;
Xiao, Jing Chen ;
Huang, Cathy C. R. -R. ;
Shen, Chun-Pyn ;
Stribling, D. Sloan ;
Shearman, Lauren P. ;
Strack, Alison M. ;
MacIntyre, D. Euan ;
Hale, Jeffrey J. ;
Walsh, Thomas F. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) :2591-2594
[5]   Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists [J].
Debenham, JS ;
Madsen-Duggan, CB ;
Walsh, TF ;
Wang, JY ;
Tong, XC ;
Doss, GA ;
Lao, J ;
Fong, TM ;
Schaeffer, MT ;
Xiao, JC ;
Huang, CRRC ;
Shen, CP ;
Feng, Y ;
Marsh, DJ ;
Stribling, DS ;
Shearman, LP ;
Strack, AM ;
MacIntyre, DE ;
Van der Ploeg, LHT ;
Goulet, MT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) :681-685
[6]   Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia [J].
Despres, JP ;
Golay, A ;
Sjostrom, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2121-2134
[7]   Discovery of 2-(2-Chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8-(5H)-one (PF-514273), a Novel, Bicyclic Lactam-Based Cannabinoid-1 Receptor Antagonist for the Treatment of Obesity [J].
Dow, Robert L. ;
Carpino, Philip A. ;
Hadcock, John R. ;
Black, Shawn C. ;
Iredale, Philip A. ;
DaSilva-Jardine, Paul ;
Schneider, Steven R. ;
Paight, Ernest S. ;
Griffith, David A. ;
Scott, Dennis O. ;
O'Connor, Rebecca E. ;
Nduaka, Chudy I. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) :2652-2655
[8]   Healthcare utilization and outcomes after bariatric surgery [J].
Encinosa, William E. ;
Bernard, Didem M. ;
Chen, Chi-Chang ;
Steiner, Claudia A. .
MEDICAL CARE, 2006, 44 (08) :706-712
[9]   Recent Improvements in Bariatric Surgery Outcomes [J].
Encinosa, William E. ;
Bernard, Dideni M. ;
Du, Dongyi ;
Steiner, Claudia A. .
MEDICAL CARE, 2009, 47 (05) :531-535
[10]  
FELDER CC, 1995, MOL PHARMACOL, V48, P443